NDC 60687-252-40 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60687-252
- Requested NDC
- 60687-252-40
- Package NDCs from labels
- 60687-252-40, 60687-252-46, 60687-252-86
- Manufacturer
- American Health Packaging
- Effective date
- 2026-06-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - American Health Packaging | American Health Packaging | 2026-06-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-252-40 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 10 | |
| 60687-252-46 | Ondansetron | 10 in 1 TRAY | SOLUTION | 10 | 10 | |
| 60687-252-86 | Ondansetron | 3 in 1 CASE | SOLUTION | 3 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60687-252-40 | ML - Milliliter | 60687-252 | fff1e0d4-f8fc-41ab-9408-bee8420c5db1 | 1 | 2019-02-13 |
| 60687-252-46 | ML - Milliliter | 60687-252 | f339fc5c-dfb6-4593-83b5-71e2ea605b09 | 1 | 2019-02-13 |
| 60687-252-86 | ML - Milliliter | 60687-252 | 29cfca47-9dfd-4852-9f12-f8fb32ce50a3 | 1 | 2019-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON | Gland Pharma Limited | 35716914-ac73-43c0-9aa0-09c99211d941 | 2025-07-31 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Gland Pharma Limited | 3efa5604-96c3-42a0-8e99-b3de4a66aa92 | 2025-07-31 | Warnings, Adverse reactions | NMH84OZK2B |
| Doctor Butler Hemorrhoid and Fissure Advanced Formula | GLYCERIN 37.5%, LANOLIN 12.5%, LIDOCAINE 4%, ZINC OXIDE 5% | Beyond Health, PA | d2a769e2-afd0-aed2-e053-2995a90ad429 | 2025-07-23 | Warnings | PDC6A3C0OX |
| Cold Sore Fast-Acting Pain Relief | GLYCERIN AND LIDOCAINE | Blistex Inc. | c7511322-dd6c-441c-bf7d-ad4f0c14956a | 2025-07-22 | Warnings | PDC6A3C0OX |
| Cureforte Breath Reset | MOUTH SPRAY | STEEL CITY HEALTH PRIVATE LIMITED | 38ddf1a7-29ab-cb8d-e063-6294a90ad34c | 2025-07-21 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PHOENIX RX LLC | 3a76bae2-04c2-ee2d-e063-6394a90ad4c8 | 2025-07-21 | Warnings, Adverse reactions | NMH84OZK2B |
| GoodSense Hemorrhoidal Pain Relief | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Perrigo Direct, Inc | 2e5f699d-45e8-6451-e063-6394a90a8ad8 | 2025-07-20 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Aurobindo Pharma Limited | 57578387-1918-4e56-a564-f14fb22340bf | 2025-07-19 | Warnings, Adverse reactions | NMH84OZK2B |
| SilkTears | GLYCERIN OPHTHALMIC SOLUTION | SilkTears | 3866e2c1-051b-0b01-e063-6394a90af5cf | 2025-07-16 | Warnings | PDC6A3C0OX |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | XF417D3PSL |
| Nikzon Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, AND PRAMOXINE HYDROCHLORIDE | Genomma Lab USA | 8f9a9939-2c99-489f-b597-9a51ec2684f9 | 2025-07-14 | Warnings | PDC6A3C0OX |
| Endocrinpath | ALFALFA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CEANOTHUS AMERICANUS, CITRICUM ACIDUM, FUCUS VESICULOSUS, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYDROCOTYLE ASIATICA, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, PANCREAS SUIS, PHYTOLACCA DECANDRA, PITUITARUM POSTERIUM (BOVINE), SARSAPARILLA (SMILAX REGELII), SILICEA, SYZYGIUM JAMBOLANUM, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corporation | 70f84941-b8a1-48f4-9c05-554e554f0049 | 2025-07-11 | Warnings | XF417D3PSL |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
| Maximum Strength Hemorrhoidal Cream with Aloe | GLYCERIN, PHENYLEPHINE HCI, PRAMOXINE HCI, PETROLATUM | Chain Drug Marketing Association | 396ea654-8be1-591a-e063-6294a90a11e2 | 2025-07-08 | Warnings | PDC6A3C0OX |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | Aurobindo Pharma Limited | cf10d256-dd89-4a91-a3ed-81db505a79c2 | 2025-07-08 | Warnings, Adverse reactions | 312085 NMH84OZK2B |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Belleview Biosciences LLC | 3245e0e5-5e7f-c3f7-e063-6394a90ac258 | 2025-07-07 | Adverse reactions | 1Q73Q2JULR XF417D3PSL |
| Hemorrhoidal Cream | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 38cf4e43-280b-eb96-e063-6294a90a5949 | 2025-07-02 | Warnings | PDC6A3C0OX |
| SEFUDUN FUNGAL NAIL PATCHES | GLYCERIN | Shenzhen Shandian Jingling Technology Co., Ltd. | 38db97d6-27c8-da99-e063-6294a90aac66 | 2025-07-01 | Warnings | PDC6A3C0OX |
| ONDANSETRON | ONDANSETRON HYDROCHLORIDE | Dr. Reddy's Laboratories Limited | 162f2088-9fb1-47e7-b88c-45104be7e7bb | 2025-06-30 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON HYDROCHLORIDE | ONDANSETRON HYDROCHLORIDE | Baxter Healthcare Corporation | 729d865f-d84a-495e-9456-4bceebb6e03f | 2025-06-30 | Warnings, Adverse reactions | NMH84OZK2B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.